FDA to Create Office of Integrity and Accountability
Most recent news releases discussing the reputation of the FDA have failed to combine the words FDA, integrity and accountability. Instead, many news stories have included words that convey the opposite message, including, for example, the words deficiencies and "culture of approval." But alas, for critics, at least, it appears that the barrage of negative media spin and congressional testimony has grabbed the attention of FDA Commissioner Andrew von Eschenbach, forcing him to issue a response.
Seemingly to combat recent allegations, von Eschenbach announced the creation of the FDA Office of Integrity and Accountability at PhRMA's board meeting held on March 15. According to FDA News, von Eschenbach stated at the meeting that the mission of the new office will be to ensure that the FDA is "scientific in perspective" and brings "precision to regulations." The deputy commissioner of policy will oversee the office.
Indeed, given the steady attacks launched against the FDA, such an office seems to be necessary, appropriate and perhaps, at least according to critics, even overdue. Whether the new office will actually achieve its mission and calm the criticism, however, remains to be seen.
